Aditxt, Inc. (ADTX)
0.0281
-0.02
(-43.69%)
USD |
NASDAQ |
Jun 09, 16:00
0.0291
0.00 (0.00%)
After-Hours: 17:25
Aditxt EPS Diluted (Quarterly) : -790.51 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Athersys, Inc. | -- |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.19M |
| Revenue (Quarterly) | 0.0122M |
| Total Expenses (Quarterly) | 15.96M |
| Enterprise Value | 3.509M |
| Gross Profit Margin (Quarterly) | -375.4% |
| Profit Margin (Quarterly) | -132.7K% |
| Earnings Yield | -726.0M% |
| Normalized Earnings Yield | -466.80M |